What's Happening?
A report by the Children’s Commissioner reveals that 41% of children have seen online ads for prescription-only weight-loss drugs like Ozempic and Mounjaro, despite a ban in England. The survey, involving 2,000 children aged 13-17, found that girls were
more likely than boys to encounter these ads. The report highlights issues with online pharmacies' verification processes and the influence of social media in promoting these drugs. The findings raise concerns about the accessibility and regulation of weight-loss drugs among minors.
Why It's Important?
The exposure of children to weight-loss drug advertisements poses significant public health and regulatory challenges. It highlights the gaps in digital advertising regulations and the need for stricter enforcement to protect minors from potentially harmful products. The situation underscores the influence of social media and online platforms in shaping young people's perceptions of health and body image. Addressing these issues is crucial to prevent the misuse of weight-loss drugs and to ensure the safety and well-being of young consumers.
